Identification of DNA methylation signatures of smoking in women and associations with cardiovascular disease mortality
Document Type
Journal Article
Publication Date
6-9-2026
Journal
Communications biology
DOI
10.1038/s42003-026-10454-y
Abstract
Tobacco smoking is critical risk factor for cardiovascular disease (CVD) and mortality, with epigenetics implicated as a key biological mechanism. Smoking disproportionately impacts CVD risk in women; however, limited research has examined smoking-associated DNA methylation (DNAm) changes in women. We measure whole blood DNAm (EPICv2) and self-reported smoking (three-category, pack-years, and years since cessation) via questionnaires in 6,005 Women's Health Initiative Memory Study participants. We perform epigenome-wide association studies and develop epigenetic predictors of each smoking phenotype, and compare DNAm and self-reported pack-years for CVD-related and all-cause mortality prediction. Here we find 20,388 FDR-significant sites related to current smoking, 2149 for former smoking, 14,709 for pack-years, and 753 for smoking cessation. The epigenetic predictors of smoking activity are highly correlated with their respective phenotypes and DNAm pack-years outperforms self-reported pack-years in mortality prediction. We report robust validation of previous findings, novel smoking associations in women, and introduce epigenetic predictors of smoking activity.
APA Citation
Khodasevich, Dennis; Shadyab, Aladdin H.; Maihofer, Adam X.; Nievergelt, Caroline M.; Wallace, Robert; Martin, Lisa W.; Bozack, Anne K.; de la Rosa, Rosemarie; Stefanick, Marcia L.; Franceschini, Nora; and Cardenas, Andres, "Identification of DNA methylation signatures of smoking in women and associations with cardiovascular disease mortality" (2026). GW Authored Works. Paper 9338.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/9338
Department
Medicine